Irina Vetter
Irina Vetter
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
RC Coll, AAB Robertson, JJ Chae, SC Higgins, R Muñoz-Planillo, ...
Nature medicine 21 (3), 248-255, 2015
Methods used to evaluate pain behaviors in rodents
JR Deuis, LS Dvorakova, I Vetter
Frontiers in molecular neuroscience 10, 284, 2017
Pathophysiology of chemotherapy-induced peripheral neuropathy
H Starobova, I Vetter
Frontiers in molecular neuroscience 10, 174, 2017
Conus venom peptide pharmacology
RJ Lewis, S Dutertre, I Vetter, MDJ Christie
Pharmacological reviews 64 (2), 259-298, 2012
Evolution of separate predation-and defence-evoked venoms in carnivorous cone snails
S Dutertre, AH Jin, I Vetter, B Hamilton, K Sunagar, V Lavergne, ...
Nature communications 5 (1), 3521, 2014
Venomics: a new paradigm for natural products-based drug discovery
I Vetter, JL Davis, LD Rash, R Anangi, M Mobli, PF Alewood, RJ Lewis, ...
Amino acids 40, 15-28, 2011
An animal model of oxaliplatin-induced cold allodynia reveals a crucial role for Nav1. 6 in peripheral pain pathways
JR Deuis, K Zimmermann, AA Romanovsky, LD Possani, PJ Cabot, ...
Pain® 154 (9), 1749-1757, 2013
Pharmacological characterisation of the highly NaV1.7 selective spider venom peptide Pn3a
JR Deuis, Z Dekan, JS Wingerd, JJ Smith, NR Munasinghe, RF Bhola, ...
Scientific reports 7 (1), 40883, 2017
NaV1. 7 as a pain target–from gene to pharmacology
I Vetter, JR Deuis, A Mueller, MR Israel, H Starobova, A Zhang, LD Rash, ...
Pharmacology & therapeutics 172, 73-100, 2017
The μ opioid agonist morphine modulates potentiation of capsaicin-evoked TRPV1 responses through a cyclic AMP-dependent protein kinase A pathway
I Vetter, BD Wyse, GR Monteith, SJ Roberts-Thomson, PJ Cabot
Molecular pain 2, 1744-8069-2-22, 2006
Selenoether oxytocin analogues have analgesic properties in a mouse model of chronic abdominal pain
AD De Araujo, M Mobli, J Castro, AM Harrington, I Vetter, Z Dekan, ...
Nature communications 5 (1), 3165, 2014
Ciguatoxins activate specific cold pain pathways to elicit burning pain from cooling
I Vetter, F Touska, A Hess, R Hinsbey, S Sattler, A Lampert, M Sergejeva, ...
The EMBO journal 31 (19), 3795-3808, 2012
Animal toxins—Nature’s evolutionary-refined toolkit for basic research and drug discovery
V Herzig, B Cristofori-Armstrong, MR Israel, SA Nixon, I Vetter, GF King
Biochemical pharmacology 181, 114096, 2020
Therapeutic potential of cone snail venom peptides (conopeptides)
I Vetter, R J Lewis
Current topics in medicinal chemistry 12 (14), 1546-1552, 2012
Characterization of endogenous calcium responses in neuronal cell lines
I Vetter, RJ Lewis
Biochemical pharmacology 79 (6), 908-920, 2010
A Bayesian model predicts the response of axons to molecular gradients
D Mortimer, J Feldner, T Vaughan, I Vetter, Z Pujic, WJ Rosoff, K Burrage, ...
Proceedings of the National Academy of Sciences 106 (25), 10296-10301, 2009
Endogenous opioid analgesia in peripheral tissues and the clinical implications for pain control
D Kapitzke, I Vetter, PJ Cabot
Therapeutics and clinical risk management 1 (4), 279-297, 2005
Analgesic Effects of GpTx-1, PF-04856264 and CNV1014802 in a Mouse Model of NaV1.7-Mediated Pain
JR Deuis, JS Wingerd, Z Winter, T Durek, Z Dekan, SR Sousa, ...
Toxins 8 (3), 78, 2016
Burn pain: a systematic and critical review of epidemiology, pathophysiology, and treatment
M Morgan, JR Deuis, M Frøsig-Jørgensen, RJ Lewis, PJ Cabot, PD Gray, ...
Pain medicine 19 (4), 708-734, 2018
Convergent evolution of pain-inducing defensive venom components in spitting cobras
TD Kazandjian, D Petras, SD Robinson, J van Thiel, HW Greene, ...
Science 371 (6527), 386-390, 2021
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20